Concomitant Tarceva® and Irradiation in Patients in Local-regionally Advanced Non-small Cell Lung Cancer. A Phase II Study
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Local failure free survival at 9 months after start of radiotherapy evaluated at CT scan
May 2012
No
Olfred Hansen, MD
Principal Investigator
Odense University Hospital
Denmark: Danish Dataprotection Agency
09.02
NCT00888511
May 2009
April 2012
Name | Location |
---|